Nasdaq Winners To Watch: ONCS, MTCR, METX, AVGR, ZIOP
Following were the key stock NASDAQ gainers on Thursday. Keep an eye on these stocks.
OncoSec Medical Incorporated (NASDAQ:ONCS) was one of the notable gainers as the stock soared 11% to close at $0.80. The stock saw total volume of over 774k shares exchanged hands, compared to its average volume of 210K shares. The stock opened at $1.60 and moved within a range of $1.5602 – 1.8290. The stock has fallen 75% so far this year. The stock is trading 17% below its 52-week high and 74% higher from its 52-week low.
Metacrine Inc. (NASDAQ:MTCR) was in the bullish trend on Thursday as the stock surged 8.77% to end the session at $1.24. After opening at $1.16, the stock has moved within a wide range of $1.1100 – 1.3799. The stock has fallen 84% so far in 2021 and 52% over the past quarter. Last week, the company reported topline results from its Phase 2a trial of MET409 in combination with Eli Lilly And Co’s (NYSE: LLY) Jardiance (empagliflozin) in type 2 diabetes and non-alcoholic steatohepatitis (NASH).
Meten Holding Group Ltd. (NASDAQ:METX) was another winner in the small cap category. The stock was up 6.74% at $0.46. More than 54.16 million shares have been traded hands, compared to its average volume of 94.67 million shares. Over the past 52-week, the stock moved within a range of $0.2800 – 4.2700. The stock has fallen 11% in the past quarter. The stock is trading 63% below its 52-week high and 89% higher from its 52-week low.
Avinger, Inc. (NASDAQ:AVGR) was in the bullish trend on Thursday as the stock moved up 5.41% to end the session at $0.77. After opening at $0.73, the stock has moved within a wide range of $0.6900 – 0.7945. The stock has jumped 75% so far in 2021 and moved up 3% over the past month.
ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) was in the bullish trend on Thursday as the stock moved up 3.68% to end the session at $1.41. After opening at $1.42, the stock has moved within a wide range of $1.3550 – 1.4300. The stock has slumped 44% so far in 2021 and moved down 15% over the past month.
This sponsored coverage is part of an investor education program.